blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0627921

EP0627921 - METHOD OF INHIBITING CARCINOGENESIS BY TREATMENT WITH DEHYDROEPIANDROSTERONE AND ANALOGS THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.2001
Database last updated on 26.07.2024
Most recent event   Tooltip25.08.2006Lapse of the patent in a contracting state
New state(s): MC
published on 27.09.2006  [2006/39]
Applicant(s)For all designated states
EAST CAROLINA UNIVERSITY
210 Spilman Building
Greenville, NC 27858-4353 / US
[1994/50]
Inventor(s)01 / NYCE, Jonathan W.
1244 Treybrooke Circle
Greenville, NC 27834 / US
[1994/50]
Representative(s)Horner, Martin Grenville, et al
Marks & Clerk LLP
Aurora
120 Bothwell Street
Glasgow
G2 7JS / GB
[N/P]
Former [1994/50]Horner, Martin Grenville, et al
Cruikshank & Fairweather 19 Royal Exchange Square
Glasgow G1 3AE Scotland / GB
Application number, filing date93906193.323.02.1993
[1994/50]
WO1993US01637
Priority number, dateUS1992084051024.02.1992         Original published format: US 840510
[1994/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9316704
Date:02.09.1993
Language:EN
[1993/21]
Type: A1 Application with search report 
No.:EP0627921
Date:14.12.1994
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.1993 takes the place of the publication of the European patent application.
[1994/50]
Type: B1 Patent specification 
No.:EP0627921
Date:31.05.2000
Language:EN
[2000/22]
Search report(s)International search report - published on:US02.09.1993
(Supplementary) European search report - dispatched on:EP11.01.1995
ClassificationIPC:A61K31/56, A61K31/12
[1994/50]
CPC:
A61K31/565 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
A61P9/00 (EP)
C-Set:
A61K31/565, A61K2300/00 (US,EP);
A61K31/565, A61K31/12 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1994/50]
TitleGerman:VERFAHREN ZUR HEMMUNG DER KARZINOGENESE DURCH BEHANDLUNG MIT DEHYDROEPIANDROSTERON UND DESSEN ANALOGE[1994/50]
English:METHOD OF INHIBITING CARCINOGENESIS BY TREATMENT WITH DEHYDROEPIANDROSTERONE AND ANALOGS THEREOF[1994/50]
French:PROCEDE D'INHIBITION DE LA CARCINOGENESE A L'AIDE D'UN TRAITEMENT A LA DESHYDROEPIANDROSTERONE ET SES ANALOGUES[1994/50]
Entry into regional phase22.09.1994National basic fee paid 
22.09.1994Search fee paid 
22.09.1994Designation fee(s) paid 
22.09.1994Examination fee paid 
Examination procedure02.08.1993Request for preliminary examination filed
International Preliminary Examining Authority: US
22.09.1994Examination requested  [1994/50]
26.02.1998Despatch of a communication from the examining division (Time limit: M06)
07.09.1998Reply to a communication from the examining division
13.10.1998Despatch of a communication from the examining division (Time limit: M02)
07.12.1998Reply to a communication from the examining division
08.02.1999Despatch of communication of intention to grant (Approval: Yes)
16.08.1999Communication of intention to grant the patent
17.11.1999Fee for grant paid
28.12.1999Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
16.02.2000Fee for publishing/printing paid
Opposition(s)01.03.2001No opposition filed within time limit [2001/20]
Request for further processing for:19.01.2000Request for further processing filed
16.02.2000Full payment received (date of receipt of payment)
Request granted
06.03.2000Decision despatched
Fees paidRenewal fee
23.02.1995Renewal fee patent year 03
08.02.1996Renewal fee patent year 04
10.02.1997Renewal fee patent year 05
25.02.1998Renewal fee patent year 06
25.02.1999Renewal fee patent year 07
11.02.2000Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT31.05.2000
BE31.05.2000
CH31.05.2000
GR31.05.2000
LI31.05.2000
NL31.05.2000
DK31.08.2000
PT31.08.2000
SE31.08.2000
IE23.02.2001
LU23.02.2001
MC28.02.2001
[2006/39]
Former [2004/39]AT31.05.2000
BE31.05.2000
CH31.05.2000
GR31.05.2000
LI31.05.2000
NL31.05.2000
DK31.08.2000
PT31.08.2000
SE31.08.2000
IE23.02.2001
LU23.02.2001
Former [2004/07]AT31.05.2000
BE31.05.2000
CH31.05.2000
GR31.05.2000
LI31.05.2000
NL31.05.2000
DK31.08.2000
PT31.08.2000
SE31.08.2000
IE23.02.2001
Former [2003/45]AT31.05.2000
BE31.05.2000
CH31.05.2000
LI31.05.2000
NL31.05.2000
DK31.08.2000
PT31.08.2000
SE31.08.2000
IE23.02.2001
Former [2003/08]AT31.05.2000
BE31.05.2000
CH31.05.2000
LI31.05.2000
NL31.05.2000
PT31.08.2000
SE31.08.2000
IE23.02.2001
Former [2002/14]AT31.05.2000
BE31.05.2000
CH31.05.2000
LI31.05.2000
PT31.08.2000
SE31.08.2000
IE23.02.2001
Former [2002/02]AT31.05.2000
BE31.05.2000
CH31.05.2000
LI31.05.2000
PT31.08.2000
SE31.08.2000
Former [2001/27]AT31.05.2000
BE31.05.2000
PT31.08.2000
SE31.08.2000
Former [2001/16]AT31.05.2000
BE31.05.2000
PT31.08.2000
Former [2001/11]AT31.05.2000
BE31.05.2000
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[Y]US4956355  (PRENDERGAST PATRICK T [IE]);
 [Y]US5001119  (SCHWARTZ ARTHUR G [US], et al)
 [Y]  - Journal of Clinical Pharmacology, Volume 30, issued 1990, GREENBERG et al.: "Co-Enzyme Q10: A New Drug for Cardiovascular Disease", pages 596-608.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.